74450-59-2

Basic information

• Product Name: 4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER
• Synonyms: 4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER;ETHYL 4-AMINO-2-METHYLBENZOATE
• CAS NO: 74450-59-2
• Molecular Formula: C₁₀H₁₃NO₂
• Molecular Weight: 179.22
• Product Categories: Aromatic Esters
• Mol File: 74450-59-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER(74450-59-2)
• EPA Substance Registry System: 4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER(74450-59-2)

Safety Data

• Hazardous Substances Data: 74450-59-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to serve as a building block in the creation of diverse drug molecules.
Used in Organic Synthesis:
4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER is used as a versatile compound in organic synthesis for its capacity to be transformed into a range of organic compounds, contributing to the development of new chemical entities.
Used in Agrochemicals:
4-AMINO-2-METHYLBENZOIC ACID ETHYL ESTER is used as a precursor in the production of agrochemicals, such as pesticides and herbicides, due to its potential to be incorporated into the molecular structures of these compounds.

Upstream product

• 62621-10-7 2-methyl-4-nitro-benzoic acid ethyl ester 

Downstream Products

• 220389-17-3 4-cyano-2-methyl-benzoic acid ethyl ester 

Relevant articles and documents

Fibrinogen receptor antagonists and their use

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.

FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE

This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.